These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11831443)

  • 1. Increased expression of CD25 and HLA-DR on lymphocytes recruited into the peritoneal cavity in non-infected CAPD patients.
    Brauner A; Hylander B; Jacobson SH; Moshfegh A; Lundahl J
    Inflammation; 2001 Dec; 25(6):399-404. PubMed ID: 11831443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients.
    de Cal M; Cruz DN; Corradi V; Nalesso F; Polanco N; Lentini P; Brendolan A; Tetta C; Ronco C
    Blood Purif; 2008; 26(3):249-54. PubMed ID: 18376106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.
    Davies SJ; Suassuna J; Ogg CS; Cameron JS
    Kidney Int; 1989 Oct; 36(4):661-8. PubMed ID: 2811064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparison of blood and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.
    Lewis SL; Bonner PN; Cooper CL; Holmes CJ
    J Clin Lab Immunol; 1992 Jan; 37(1):3-19. PubMed ID: 1339234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis.
    Griveas I; Visvardis G; Fleva A; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Paulitou A; Sakellariou G
    Ren Fail; 2005; 27(3):279-82. PubMed ID: 15957543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity.
    Brauner A; Lu Y; Halldén G; Hylander B; Lundahl J
    Inflammation; 1998 Feb; 22(1):55-66. PubMed ID: 9484650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Clin Immunol Immunopathol; 1990 Aug; 56(2):151-8. PubMed ID: 2379325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis.
    Grzegorzewska AE; Leander M
    Adv Perit Dial; 2001; 17():10-4. PubMed ID: 11510253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes.
    Langhoff E; Ladefoged J; Odum N
    Int Arch Allergy Appl Immunol; 1986; 81(1):5-11. PubMed ID: 3488966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous ambulatory peritoneal dialysis impairs T lymphocyte selection in the peritoneum.
    Fricke H; Hartmann J; Sitter T; Steldinger R; Rieber P; Schiffl H
    Kidney Int; 1996 May; 49(5):1386-95. PubMed ID: 8731104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.
    Wasik M; Blaim M; Kolewska D; Janota-Krawczyk E; Tomaszewska-Pańczyk M; Sieniawska M
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Abnormalities of cellular immunity in uremic patients].
    Matsumoto Y
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):733-42. PubMed ID: 8377286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytes subsets in the course of continuous ambulatory peritoneal dialysis (CAPD).
    Griveas I; Visvardis G; Fleva A; Papadopoulou D; Mitsopoulos E; Nikopoulos K; Manou E; Kyriklidou P; Ginikopoulou E; Meimaridou D; Pavlitou A; Sakellariou G
    Ren Fail; 2004 Nov; 26(6):641-6. PubMed ID: 15600255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation.
    Libetta C; De Nicola L; Rampino T; De Simone W; Memoli B
    Kidney Int; 1996 Feb; 49(2):506-11. PubMed ID: 8821837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved lymphocyte transformation in vitro of patients on continuous ambulatory peritoneal dialysis.
    Langhoff E; Ladefoged J
    Proc Eur Dial Transplant Assoc; 1983; 20():230-5. PubMed ID: 6657659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.